4.23 0.73 (20.86%)
4:00 PM ET 12/02/09
Company Profile
Price and Volume
Recent Price 3.50
52 Week High 4.39
52 Week Low 1.55
Avg. Daily Vol. (Mil) 0.47
Beta (3 year) 1.88
Share Related Items
Mkt Cap (Mil) 273.17
Shares Out (Mil) 78.05
Float (Mil) 70.31
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.00
Current Ratio 2.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.84
Price/Book 0.00
Price/Cash Flow -6.50
Per Share Data
Earnings -0.68
Sales 0.60
Book Value 0.00
Cash Flow -0.54
Business Summary
A clinical stage biotechnology company, which is engaged in the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.
General Information
300 Technology Square
Cambridge, MA 02139
www.dyax.com
Industry : Drugs
Sector: Health Care
Employees: 164
CEO: Gustav A. Christensen
Short Interest
Current Month (Mil) 2.89
Previous Month (Mil) 2.40
Short Interest Ratio (Days) 7.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -87.40
Return on Investments -464.00
Profitability
Gross Margin n.a.
EBIT Margin -76.10
Profit Margin -96.40
Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.68 1,109.24 2,185.03 33.23
Oil *
77.73
DOWN
18.90
UP
0.38
UP
9.22
UP
0.48
10 Yr
3.32%
SPDR Gold
119.18
-0.18%
+0.03%
+0.42%
+1.47%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services